Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. PTCT
PTCT logo

PTCT

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PTCT News

PTC Appoints Biotechnology Investment Banker to Board

5d agoPRnewswire

PTC Appoints Biotechnology Expert to Board

5d agoNewsfilter

RTW Investments Takes New Stake in Apellis Pharmaceuticals

Mar 22 2026Yahoo Finance

RTW Investments Increases Stake in Cogent Biosciences by $116 Million

Mar 22 2026Yahoo Finance

PTC Therapeutics Approves Employee Stock Options

Mar 13 2026PRnewswire

PTC Therapeutics Approves Employee Stock Options

Mar 13 2026Newsfilter

UniQure's Gene Therapy Faces FDA Challenges

Mar 05 2026CNBC

Palo Alto Investors Increases Stake in PTC Therapeutics

Mar 03 2026Fool

PTC Therapeutics Announces Upcoming Conference Schedule

Feb 23 2026PRnewswire

PTC Therapeutics Q4 2025 Earnings Call Highlights

Feb 20 2026seekingalpha

Phenylketonuria Treatment Market Outlook Analysis

Feb 18 2026Newsfilter

PTC Therapeutics Withdraws New Drug Application for Translarna

Feb 13 2026Benzinga

PTC Therapeutics Withdraws NDA Resubmission for Translarna

Feb 12 2026seekingalpha

PTC Therapeutics Withdraws NDA for Translarna Due to FDA Feedback

Feb 12 2026PRnewswire

PTC Therapeutics Withdraws NDA for Translarna Due to FDA Feedback

Feb 12 2026Newsfilter

Rare Disease Biotechs Show Strong 2025 Performance with Cashflow and R&D Expansion

Jan 14 2026Yahoo Finance